Erlotinib-Induced Trichomegaly of Eyelashes in Lung Cancer Treatment: Epidermal Growth Factor Receptor Inhibitor Side Effect

GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.

Minoxidil use led to significant eyelash and eyebrow growth, making the user appear more feminine. The user hopes for similar results on scalp hair.

The user experienced significant eyebrow and eyelash growth after starting a hair loss treatment routine that includes oral minoxidil, oral dutasteride, topical minoxidil, Nizoral shampoo, microneedling, and supplements. They also reported positive scalp hair gains and no significant side effects.

ET-02, a new hair loss treatment, shows promising results with a 6-fold increase in hair count, potentially outperforming minoxidil by activating stem cells in hair follicles. Further trials are ongoing to confirm its efficacy and safety, with potential market release in the future.

Minoxidil, dutasteride, and finasteride treatments have significantly increased eyelash length, with some users experiencing eyelashes over twice the average length. Many users report increased hair growth in unintended areas, such as knuckles and body hair, while still struggling with hair loss on the scalp.

Applying Epidermal Growth Factor (EGF) topically may improve skin and potentially promote scalp health and hair growth, especially after microneedling. The user shares their positive experience with EGF and provides a product link.